Recent Advances in the Synthesis and Biological Activity of Pyrrolo[2,3-c]pyridines-Reference-Cited by-同舟云学术

Recent Advances in the Synthesis and Biological Activity of Pyrrolo[2,3-c]pyridines

Published:2024-06-19 Issue:1 Volume:22 Page:33-56
ISSN:2518-1548
Container-title:Journal of Organic and Pharmaceutical Chemistry
language:
Short-container-title:J. Org. Pharm. Chem.

Author:

Voloshchuk Volodymyr V.¹^ORCID,Ivonin Sergey P.²

Affiliation:

1. Institute of Organic Chemistry of the National Academy of Sciences of Ukraine; Enamine Ltd.

2. Institute of Organic Chemistry of the National Academy of Sciences of Ukraine

Abstract

Pyrrolo[2,3-c]pyridines (6-azaindoles) are the most promising nitrogen-containing heterocyclic compounds in the field of drug development. Exhibiting extraordinary versatility as pharmacophores, they are widely used in the development of kinase inhibitors, antiproliferative agents, and as potential therapeutic agents for the treatment of various diseases, including cancer and Alzheimer’s disease. A large number of works focusing on new methods and approaches in the synthesis of 6-azaindoes, as well as on the study of their biological activity, have been published worldwide. In our review, we tried to classify all currently known strategies for the construction of the 6-azaindole core, which were published within the last 15 years, the chemical diversity of the derivatives obtained, and their therapeutic potential in the context of medicinal chemistry. We hope that this work will generalize and facilitate the understanding of the strategy for the synthesis of pyrrolo[2,3-c]pyridines, as well as help scientists in their further research in the direction of 6-azaindoles.

Publisher

National University of Pharmacy

Reference84 articles.

1. Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014, 57 (22), 10257–10274. https://doi.org/10.1021/jm501100b.

2. Popowycz, F.; Mérour, J.-Y.; Joseph, B. Synthesis and Reactivity of 4-, 5- and 6-azaindoles. Tetrahedron 2007, 63 (36), 8689–8707. https://doi.org/10.1016/j.tet.2007.05.078.

3. Blaazer, A. R.; Lange, J. H. M.; van der Neut, M. A. W.; Mulder, A.; den Boon, F. S.; Werkman, T. R.; Kruse, C. G.; Wadman, W. J. Novel Indole and Azaindole (Pyrrolopyridine) Cannabinoid (CB) Receptor Agonists: Design, Synthesis, Structure-Activity Relationships, Physicochemical Properties and Biological Activity. Eur. J. Med. Chem. 2011, 46 (10), 5086–5098. https://doi.org/10.1016/j.ejmech.2011.08.021.

4. Ganser, C.; Lauermann, E.; Maderer, A.; Stauder, T.; Kramb, J.-P.; Plutizki, S.; Kindler, T.; Moehler, M.; Dannhardt, G. Novel 3‑Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity. J. Med. Chem. 2012, 55 (22), 9531–9540. https://doi.org/10.1021/jm301217c.

5. Lee, H.-Y.; Tsai, A.-C.; Chen, M.-C.; Shen, P.-J.; Cheng, Y.-C.; Kuo, C.-C.; Pan, S.-L.; Liu, Y.-M.; Liu, J.-F.; Yeh, T.-K.; Wang, J.-C.; Chang, C.-Y.; Chang, J.-Y.; Liou, J.-P. Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells. J. Med. Chem. 2014, 57 (10), 4009–4022. https://doi.org/10.1021/jm401899x.